Associations of LOXL3 expression with EMT (through E-cadherin transcription repression by SNAIL) [55,56], cell invasion in breast cancer [57], and with GBM cell adhesion and invasion [10] have been described. This evidence concerns the gene LOXL3 and breast carcinoma.